| PG |
Report |
Core EPS (FQ4'26) |
IN-LINE |
pred ~$1.43 vs. cons $1.42 |
MEDIUM |
| PG |
Report |
Organic sales growth (FQ4'26) |
IN-LINE |
pred ~2.3% vs. cons 2.1% |
MEDIUM |
| PG |
Report |
Core gross margin (FQ4'26) |
MISS |
pred ~48.0% vs. cons 48.4% |
LOW |
| PG |
Guide |
FY27 core EPS growth guide (the swing factor) |
LOWER |
guide ~+2-4% (~$7.00-7.15) vs. cons ~+6% (~$7.25) (FY27) |
MEDIUM |
| PG |
Guide |
FY27 organic sales growth guide |
UNCHANGED |
guide ~3-4% vs. cons ~3.5% (FY27) |
MEDIUM |
| PG |
Guide |
Updated after-tax cost/oil headwind framing |
UNKNOWN |
guide ~$0.7-1.0B vs. cons prior ~$1.0B at $100 Brent (FY27) |
LOW |
| PG |
Guide |
FY26 core EPS (full-year landing) |
UNCHANGED |
guide ~$6.86 vs. cons ~$6.88, low end of $6.83-7.09 (FY26) |
MEDIUM |
| PG |
Return |
Day-1 residual (stock − beta × S&P 500) |
-1.5% |
— |
MEDIUM |
| PG |
Return |
5-day cumulative residual |
-2.5% (FOLLOW-THROUGH) |
Q4 print is roughly in-line but the make-or-break FY27 EPS guide likely lands below the ~+6% consensus as the ~$1B after-tax cost wave carries into FY27 and productivity 'won't be sufficient' to fully offset. That triggers downward FY27 estimate revisions (implicit cuts) that compound the initial drop; defensive-staple support and subdued positioning cap but don't reverse it, so the negative day-1 move follows through rather than fades. |
MEDIUM |